Results
|
3481.
|
Combined Proteomic and In Silico Target Identification Reveal a Role for 5-Lipoxygenase in Developmental Signaling Pathways. [electronic resource] by
- Brand, Silke
- Roy, Sayantani
- Schröder, Peter
- Rathmer, Bernd
- Roos, Jessica
- Kapoor, Shobhna
- Patil, Sumersing
- Pommerenke, Claudia
- Maier, Thorsten
- Janning, Petra
- Eberth, Sonja
- Steinhilber, Dieter
- Schade, Dennis
- Schneider, Gisbert
- Kumar, Kamal
- Ziegler, Slava
- Waldmann, Herbert
Producer: 20190612
In:
Cell chemical biology vol. 25
Availability: No items available.
|
|
3482.
|
|
|
3483.
|
|
|
3484.
|
|
|
3485.
|
|
|
3486.
|
|
|
3487.
|
|
|
3488.
|
|
|
3489.
|
|
|
3490.
|
Topical nonsteroidal antipsoriatic agents. 1. 1,2,3,4-Tetraoxygenated naphthalene derivatives. [electronic resource] by
- Jones, G H
- Venuti, M C
- Young, J M
- Murthy, D V
- Loe, B E
- Simpson, R A
- Berks, A H
- Spires, D A
- Maloney, P J
- Kruseman, M
Producer: 19860917
In:
Journal of medicinal chemistry vol. 29
Availability: No items available.
|
|
3491.
|
|
|
3492.
|
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man. [electronic resource] by
- Depré, M
- Van Hecken, A
- Verbesselt, R
- Verpooten, G A
- Arnout, J
- Brunner, F
- Jurgens, A
- Pousset, V
- Chow, A
- Baldauf, C
- Vermylen, J
- De Broe, M
- De Schepper, P J
Producer: 19970416
In:
International journal of clinical pharmacology research vol. 16
Availability: No items available.
|
|
3493.
|
|
|
3494.
|
|
|
3495.
|
|
|
3496.
|
|
|
3497.
|
Mitochondria are direct targets of the lipoxygenase inhibitor MK886. A strategy for cell killing by combined treatment with MK886 and cyclooxygenase inhibitors. [electronic resource] by
- Gugliucci, Arianna
- Ranzato, Laura
- Scorrano, Luca
- Colonna, Raffaele
- Petronilli, Valeria
- Cusan, Claudia
- Prato, Maurizio
- Mancini, Mariangela
- Pagano, Francesco
- Bernardi, Paolo
Producer: 20021017
In:
The Journal of biological chemistry vol. 277
Availability: No items available.
|
|
3498.
|
|
|
3499.
|
|
|
3500.
|
|